Tech Company Financing Transactions

Omthera Pharmaceuticals Funding Round

Private investors participated in a $17.6 million capital raise for Omthera Pharmaceuticals. The round was announced on 3/1/2013.

Transaction Overview

Announced On
3/1/2013
Transaction Type
Debt
Amount
$17,600,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
707 State Road
Princeton, NJ 08540
USA
Email Address
Overview
Omthera Pharmaceuticals, Inc. is an emerging specialty pharmaceuticals company with an experienced team of experts in drug development and the Pharmaceutical industry focusing its efforts on the clinical development of new therapies for dyslipidemia.
Profile
Omthera Pharmaceuticals LinkedIn Company Profile
Social Media
Omthera Pharmaceuticals Company Twitter Account
Company News
Omthera Pharmaceuticals News
Facebook
Omthera Pharmaceuticals on Facebook
YouTube
Omthera Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jerry Wisler
  Jerry Wisler LinkedIn Profile  Jerry Wisler Twitter Account  Jerry Wisler News  Jerry Wisler on Facebook
Chief Financial Officer
Christian Schade
  Christian Schade LinkedIn Profile  Christian Schade Twitter Account  Christian Schade News  Christian Schade on Facebook
Chief Medical Officer
Michael Davidson
  Michael Davidson LinkedIn Profile  Michael Davidson Twitter Account  Michael Davidson News  Michael Davidson on Facebook
Chief Operating Officer
Ben Machielse
  Ben Machielse LinkedIn Profile  Ben Machielse Twitter Account  Ben Machielse News  Ben Machielse on Facebook
Controller
Douglas Carr
  Douglas  Carr LinkedIn Profile  Douglas  Carr Twitter Account  Douglas  Carr News  Douglas  Carr on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/1/2013: UpTo venture capital transaction
Next: 3/1/2013: Novan venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary